Alchemab Therapeutics, a UK-based pharmaceutical company aiming to identify and develop naturally occurring therapeutic antibodies from resilient individuals, has announced that Jane Osbourn, Alchemab’s co-founder and CSO, has succeeded Young…
Alchemab Therapeutics, a UK-based pharmaceutical company aiming to identify and develop naturally occurring therapeutic antibodies from resilient individuals, has announced that Jane Osbourn, Alchemab’s co-founder and CSO, has succeeded Young…
…
…